2005年1月至2008年12月用倍他乐克、通心络治疗冠心病绞痛42例,疗效满意,现报道如下:1对象与方法1.1对象将83例冠心病心绞痛患者随机分为治疗组42例,对照组41例。两组患者的性别、年龄、病程、心绞痛分级、合并症等,经统计学处理无显著性差异(P>0.05)。排除标准①严重肝、肾、造血系统疾病; January 2005 to December 2008 with Betaloc, Tongxinluo treatment of coronary heart disease in 42 cases of angina pectoris, with satisfactory results are reported as follows: 1 Subjects and methods 1.1 Object 83 patients with coronary heart disease angina pectoris were randomly divided into treatment Group 42 cases, control group 41 cases. There was no significant difference (P> 0.05) between the two groups in terms of gender, age, course of disease, grade of angina pectoris and comorbidities. Exclusion criteria ① serious liver, kidney, hematopoietic system disease;